Today, companies like Larsen & Toubro, The Tata Power Company, Dabur India, Aditya Birla Capital, Procter and Gamble Hygiene ...

A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, ...

GIFT Nifty ended down by 61 points or 0.25% at 24,149 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

Piramal Pharma has broken out from a 6-week consolidation on weekly charts, now trading above key moving averages and is ...

Investments will target both domestic and US markets, with a split allocation for maintenance and capacity expansion in key ...

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 310 in its research report dated October 24, 2024.

A part of the capex is planned for the domestic market while some of it would also go into the U.S. business, the chairperson ...

Piramal Pharma is utilising a capex of about USD 85 million for various initiatives, including capacity expansion, ...

Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News ...

Piramal Pharma is investing USD 85 million this fiscal for expansion and maintenance, with USD 30 million already spent in ...

Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity ...